Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page shows a new release version tag (v3.6.5) replacing the previous v3.6.4. This indicates an internal update to the site template or backend rather than a change to the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the study details page.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision label on the page was updated from v3.6.0 to v3.6.3, indicating a minor page/version update. This change is a metadata/versioning update and does not modify substantive content or study details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe study locations count was updated to 85 locations, down from 86, indicating a reduction in participating sites and reflecting the current geographic footprint of the trial.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page gains new user guidance sections for reading the study record and joining, and clearly signals recruitment has ended; formatting tweaks to the Intervention/Treatment header and a new version label (v3.6.0) are also present.SummaryDifference0.2%

- Check72 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing the prior Revision: v3.5.4, indicating a small metadata update. There is no visible change to study content or user-facing features based on this update.SummaryDifference0.0%

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.